Literature DB >> 22302636

Biochemical predictors of cardiac rhythm at 1 year follow-up in patients with non-valvular atrial fibrillation.

Mónica Acevedo1, Ramón Corbalán, Sandra Braun, Jaime Pereira, Ilse González, Carlos Navarrete.   

Abstract

C-reactive protein (CRP) is increased in patients with atrial fibrillation (AF) and it might predict the lack of sinus rhythm maintenance in the long term follow-up. Scarce data have been reported relating endothelial dysfunction and/or haemostatic or platelet markers to sinus rhythm maintenance in AF patients. We aimed to determine whether some biochemical markers including soluble thrombomodulin (sTM), soluble P-selectin, thrombin-antithrombin (TAT) complex and CRP levels could predict sinus rhythm maintenance at 1 year follow-up in non-valvular AF patients. 130 patients (70 males, mean age 67 ± 13 years) with newly diagnosed AF naïve of antithrombotic or antiplatelet therapy were studied. Baseline CRP, P-selectin, sTM and TAT levels were compared to those of 20 matched-healthy subjects in sinus rhythm. AF patients had significantly higher plasma CRP (10.5 ± 2.2 vs 3.25 ± 0.3 mg/l, p = 0.001), P-selectin (219 ± 141 vs 126 ng/ml, p = 0.01), and TAT (54 ± 237 vs 2.7 ± 3.3 ng/l, p = 0.001) levels compared with controls. Soluble TM levels, although higher than controls, did not reach statistical significance. Multivariate regression analyses showed that elevated CRP (OR = 4.8, p = 0.02) and sTM (OR = 1.05, p = 0.04) were the only two predictors of lack of sinus rhythm at 1 year follow-up. An altered inflammatory, haemostatic, endothelial and platelet environment exists in newly diagnosed AF patients. CRP and sTM levels might be used as biochemical markers to predict the status of cardiac rhythm at 1 year follow-up in some AF patients.

Entities:  

Year:  2012        PMID: 22302636     DOI: 10.1007/s11239-012-0690-1

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN: 0929-5305            Impact factor:   2.300


  36 in total

1.  Prothrombotic markers in atrial fibrillation: what is new?

Authors:  N M Al-Saady; M Sopher
Journal:  Eur Heart J       Date:  2001-09       Impact factor: 29.983

2.  Hypercoagulability and haemodynamic abnormalities in atrial fibrillation.

Authors:  G Y Lip
Journal:  Heart       Date:  1997-05       Impact factor: 5.994

3.  Systemic vascular cell adhesion molecule-1 predicts the occurrence of post-operative atrial fibrillation.

Authors:  Hugo Verdejo; Juan Roldan; Lorena Garcia; Andrea Del Campo; Elia Becerra; Mario Chiong; Rosemarie Mellado; Amalia Garcia; Ricardo Zalaquett; Sandra Braun; Bernardita Garayar; Sergio Gonzalez; Sergio Lavandero; Ramon Corbalan
Journal:  Int J Cardiol       Date:  2010-05-05       Impact factor: 4.164

4.  Histological substrate of atrial biopsies in patients with lone atrial fibrillation.

Authors:  A Frustaci; C Chimenti; F Bellocci; E Morgante; M A Russo; A Maseri
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

5.  Fibrin D-dimer and beta-thromboglobulin as markers of thrombogenesis and platelet activation in atrial fibrillation. Effects of introducing ultra-low-dose warfarin and aspirin.

Authors:  G Y Lip; P L Lip; J Zarifis; R D Watson; D Bareford; G D Lowe; D G Beevers
Journal:  Circulation       Date:  1996-08-01       Impact factor: 29.690

6.  C-reactive protein and atrial fibrillation: "evidence for the presence of inflammation in the perpetuation of the arrhythmia".

Authors:  Mónica Acevedo; Ramón Corbalán; Sandra Braun; Jaime Pereira; Carlos Navarrete; Ilse Gonzalez
Journal:  Int J Cardiol       Date:  2005-06-27       Impact factor: 4.164

7.  Usefulness of statin drugs in protecting against atrial fibrillation in patients with coronary artery disease.

Authors:  Yinong Young-Xu; Samer Jabbour; Robert Goldberg; Charles M Blatt; Thomas Graboys; Brian Bilchik; Shmuel Ravid
Journal:  Am J Cardiol       Date:  2003-12-15       Impact factor: 2.778

8.  Expression of cell adhesion molecules and the appearance of adherent leukocytes on the left atrial endothelium with atrial fibrillation: rabbit experimental model.

Authors:  N Kamiyama
Journal:  Jpn Circ J       Date:  1998-11

9.  Plasma von Willebrand factor, soluble thrombomodulin, and fibrin D-dimer concentrations in acute onset non-rheumatic atrial fibrillation.

Authors:  F Marín; V Roldán; V E Climent; A Ibáñez; A García; P Marco; F Sogorb; G Y H Lip
Journal:  Heart       Date:  2004-10       Impact factor: 5.994

10.  Thrombomodulin and tissue factor pathway inhibitor in endocardium of rapidly paced rat atria.

Authors:  Takeshi Yamashita; Akiko Sekiguchi; Yu-ki Iwasaki; Kouichi Sagara; Seiji Hatano; Hiroyuki Iinuma; Tadanori Aizawa; Long-Tai Fu
Journal:  Circulation       Date:  2003-11-10       Impact factor: 29.690

View more
  8 in total

Review 1.  Inflammation and C-reactive protein in atrial fibrillation: cause or effect?

Authors:  Roberto Galea; Maria Teresa Cardillo; Annalisa Caroli; Maria Giulia Marini; Chiara Sonnino; Maria L Narducci; Luigi M Biasucci
Journal:  Tex Heart Inst J       Date:  2014-10-01

2.  Association of circulating factor seven activating protease (FSAP) and of oral Omega-3 fatty acids supplements with clinical outcome in patients with atrial fibrillation: the OMEGA-AF study.

Authors:  Mariana S Parahuleva; Sandip Kanse; Hans Hölschermann; Kirila Zheleva; Daniel Zandt; Michael Worsch; Behnoush Parviz; Norbert Güttler; Harald Tillmanns; Andreas Böning; Ali Erdogan
Journal:  J Thromb Thrombolysis       Date:  2014-04       Impact factor: 2.300

3.  Association of hemostatic markers with atrial fibrillation: a meta-analysis and meta-regression.

Authors:  Na Wu; Shifei Tong; Ying Xiang; Long Wu; Bin Xu; Yao Zhang; Xiangyu Ma; Yafei Li; Zhiyuan Song; Li Zhong
Journal:  PLoS One       Date:  2015-04-17       Impact factor: 3.240

Review 4.  Heart failure and atrial fibrillation: from basic science to clinical practice.

Authors:  João Pedro Ferreira; Mário Santos
Journal:  Int J Mol Sci       Date:  2015-01-30       Impact factor: 5.923

Review 5.  Predictive Role of Coagulation, Fibrinolytic, and Endothelial Markers in Patients with Atrial Fibrillation, Stroke, and Thromboembolism: A Meta-Analysis, Meta-Regression, and Systematic Review.

Authors:  Alexander Weymann; Anton Sabashnikov; Sadeq Ali-Hasan-Al-Saegh; Aron-Frederik Popov; Seyed Jalil Mirhosseini; William L Baker; Mohammadreza Lotfaliani; Tong Liu; Hamidreza Dehghan; Senol Yavuz; Michel Pompeu Barros de Oliveira Sá; Jae-Sik Jang; Mohamed Zeriouh; Lei Meng; Fabrizio D'Ascenzo; Abhishek J Deshmukh; Guiseppe Biondi-Zoccai; Pascal M Dohmen; Hugh Calkins; Integrated Meta-Analysis Of Cardiac Cardiac Surgery And Cardiology-Group Imcsc-Group
Journal:  Med Sci Monit Basic Res       Date:  2017-03-31

Review 6.  Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review.

Authors:  Alexander Weymann; Sadeq Ali-Hasan-Al-Saegh; Anton Sabashnikov; Aron-Frederik Popov; Seyed Jalil Mirhosseini; Luis Nombela-Franco; Luca Testa; Mohammadreza Lotfaliani; Mohamed Zeriouh; Tong Liu; Hamidreza Dehghan; Senol Yavuz; Michel Pompeu Barros de Oliveira Sá; William L Baker; Jae-Sik Jang; Mengqi Gong; Umberto Benedetto; Pascal M Dohmen; Fabrizio D'Ascenzo; Abhishek J Deshmukh; Giuseppe Biondi-Zoccai; Hugh Calkins; Gregg W Stone; Integrated Meta-Analysis Of Cardiac Surgery And Cardiology-Group Imcsc-Group
Journal:  Med Sci Monit Basic Res       Date:  2017-03-17

Review 7.  Atrial Myopathy.

Authors:  Mark J Shen; Rishi Arora; José Jalife
Journal:  JACC Basic Transl Sci       Date:  2019-09-23

8.  Periatrial epicardial fat is associated with markers of endothelial dysfunction in patients with atrial fibrillation.

Authors:  Nicolas Girerd; Alina Scridon; Francis Bessière; Samuel Chauveau; Alain Geloen; Loic Boussel; Elodie Morel; Philippe Chevalier
Journal:  PLoS One       Date:  2013-10-15       Impact factor: 3.240

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.